SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes
NCT06149793
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis-related Diabetes
Cystic Fibrosis
Interventions
DRUG:
Empagliflozin
OTHER:
Placebo Control
Sponsor
University of Minnesota